Related Posts
Noosa Mining Investor Conference, July 2024 – Terrain Minerals (ASX:TMX)
30 Jul 2024 - Justin Virgin - Executive Director - Terrain Minerals (ASX:TMX) is a West Australian based minerals exploration company focused on the world class mineral provinces in Western Australia. Terrain is actively looking for opportunities within other states of Australia and internationally.
Read More
Acorn Capital microcap and emerging company specialist
01 May 2020 - Acorn Capital, Head of Portfolio Implementation and Portfolio manager (Healthcare and Biotechnology sectors) Paul Palumbo looks the microcap sector and the recent market sell off and discusses the outlook for next 6 months and longer term.
Read More
Radiopharm Theranostics (ASX:RAD) eyes NASDAQ listing
17 Feb 2023 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari discusses the company's upcoming plans to list on the NASDAQ and provides an update on the its clinical trials.
Read More
Empire Energy begins drilling in Beetaloo Basin
18 Nov 2024 - Empire Energy Group Limited (ASX:EEG) has commenced drilling for its Carpentaria Pilot Project after receiving environmental clearance. The initiative aims to deliver much-needed gas to the Northern Territory and east coast markets, supported by local and federal government strategies.
Read More
QX Resources (ASX:QXR) announces letter of intent with Liberty Lithium
17 May 2023 - QX Resources Limited (ASX:QXR) Managing Director Steve Promnitz discusses the company's letter of intent with Liberty Lithium, the advantages of the project, the difference between brine and hard rock lithium, and the timeline ahead.
Read More
Validation milestone for Clever Culture Systems
29 Aug 2025 - Expanding technology and market reach
Read More
Lake Resources (ASX:LKE) announces two-phase production strategy for battery-grade lithium carbonate
22 Jun 2023 - Lake Resources Limited (ASX:LKE) Managing Director David Dickson discusses the company's two-phase strategy.
Read More
Immutep (ASX:IMM) global leader in development of LAG 3 Gene immuno-therapies
24 Jun 2020 - Immutep (ASX:IMM) CEO, Marc Voigt provides an update on its clinical trials including metastatic breast cancer (MBC), its global leadership under Chief Scientist and Medical Officer, Professor Frederic Triebel, and the growing interest by big pharma in immuno-therapies.
Read More
From Stephen Hawking to basketball jump clinics: Control Bionics on the promise of EMG technology
13 Sep 2024 - Control Bionics Limited (ASX:CBL) CEO Jeremy Steele provides an overview of the company, discussing its suite of augmentative and alternative communication products.
Read More
Should an investor allocate to cryptocurrencies like Bitcoin and Ethereum?
30 May 2022 - Fred Pye, CEO and Chairman of digital asset manager 3iQ, discusses the future of cryptocurrencies and the launch of two crypto ETFs in Australia based on Ethereum and Bitcoin.
Read More